Dosage Forms & Drug Delivery Systems – Page 19

Filter Integrity Failure during aseptic filling: data integrity checks for lab and shop floor

The first indication of a filter integrity failure often stems from data anomalies or alterations in expected process parameters. Here are common signals to monitor:Click to read the full article.

Media Fill Failure during method transfer: packaging integrity and CCIT justification

Detecting early signals of media fill failure is crucial in the prevention of non-sterile production batches. Common symptoms may include:Click to read the full article.

Media Fill Failure during PAI readiness: FDA/MHRA investigation narrative and batch impact

In any media fill process, the early detection of anomalies is vital for ensuring the sterility and integrity of the product. Symptoms of media fill failure often manifest as:Click to…

High Visual Inspection Reject Rate during routine EM trending: FDA/MHRA investigation narrative and batch impact

Recognizing symptoms or signals that indicate high visual inspection reject rates is crucial for initiating an investigation. Symptoms may manifest through: Click to read the full article.

Osmolality Oos during sterile filtration: packaging integrity and CCIT justification

Identifying signals that indicate potential OOS results is critical. Symptoms can manifest in the laboratory through various means:Click to read the full article.

Texture Variability in ointment filling: how to document deviations for FDA/EMA

The first step in addressing texture variability in ointment filling is to recognize the symptoms or signals that indicate a problem. Here are some common observations that may be reported…

Phase Separation at accelerated stability: cleaning validation and worst-case selection

Symptoms of phase separation can manifest in various forms, starting from observed physical characteristics to analytical results. Key signals that should prompt investigation include:Click to read the full article.

Media Fill Failure after packaging change: FDA-ready investigation report and batch disposition

Media fill tests are a critical component of validating aseptic processing in pharmaceutical manufacturing. A failure in this area could manifest various symptoms, leading to operational and regulatory consequences. Some…

Air Entrapment during bulk hold: cleaning validation and worst-case selection

Identifying symptoms of air entrapment in bulk holds is crucial for effective troubleshooting. Symptoms may include, but are not limited to:Click to read the full article.

Assay Oos in cream manufacturing: cleaning validation and worst-case selection

The first step in addressing assay OOS in cream manufacturing is to identify any symptoms or signals that may indicate underlying issues. Specifically, these signals may include:Click to read the…

Dropper Compatibility Failure at stability pull: FDA-ready investigation report and batch disposition

Recognizing the symptoms of dropper compatibility failure early in the manufacturing or testing phase can significantly mitigate risks. Typical signals might include:Click to read the full article.

Cleaning Validation Failure after excipient change: GMP investigation and CAPA strategy

Cleaning validation failures manifest through specific symptoms, which may include:Click to read the full article.